Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus

International Journal of Antimicrobial Agents

Volumn 22, Issue SUPPL. 2, 2003, Pages 35-43

  Hoepelman, Andy I M ^a   Meiland, Ruby ^b   Geerlings, Suzanne E ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Asymptomatic bacteruria; Diabetes mellitus; Pathogenesis; Treatment; Urinary tract infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; BACTERIAL VACCINE; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; CYTOKINE; ESTROGEN; FOSFOMYCIN; MEDROXYPROGESTERONE ACETATE; NITROFURANTOIN; OFLOXACIN; PROBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BACTERIURIA; BLADDER MUCOSA; CLINICAL FEATURE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CRANBERRY; CYSTITIS; CYTOKINE RELEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; DRUG COST; ESCHERICHIA COLI; FRUIT JUICE; GLUCOSURIA; HORMONAL THERAPY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY ABSCESS; KIDNEY PAPILLA NECROSIS; LACTOBACILLUS; NEPHRECTOMY; NEUTROPENIA; PATHOGENESIS; PERCUTANEOUS DRAINAGE; PRIORITY JOURNAL; PYELONEPHRITIS; REINFECTION; RISK FACTOR; SCREENING TEST; URINARY TRACT INFECTION; URINE CULTURE; VAGINA FLORA;

EID: 0141758350     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00234-6     Document Type: Article

References (74)

1. Hooton T.M., Stamm W.E. Diagnosis and treatment of uncomplicated urinary tract infection. Infect. Dis. Clin. North Am. 11:(3):1997;551-581.
2. Barnett B.J., Stephens D.S. Urinary tract infection: an overview. Am. J. Med. Sci. 314:(4):1997;245-249.
3. Johnson J.R., Roberts P.L., Stamm W.E. P fimbriae and other virulence factors in Escherichia coli urosepsis: association with patients' characteristics. J. Infect. Dis. 156:(1):1987;225-229.
4. Hoepelman A.I.M., Van Buren M., Van den Broek P.J., et al. Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count). AIDS. 6:(2):1992;179-184.
5. Carton J.A., Maradona J.A., Nuno F.J., et al. Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur. J. Med. 1:(5):1992;281-287.
6. Baldwin A.D., Root H.F. Infections of the upper urinary tract in the diabetic patient. N. Engl. J. Med. 223:(7):1940;244-250.
7. Zhanel G.G., Harding G.K., Nicolle L.E. Asymptomatic bacteriuria in patients with diabetes mellitus. Rev. Infect. Dis. 13:(1):1991;150-154.
8. Geerlings S.E., Stolk R.P., Camps M.J.L., et al. Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Care. 23:(6):2000;744-749.
9. Forland M., Thomas V., Shelokov A. Urinary tract infections in patients with diabetes mellitus. Studies on antibody coating of bacteria. JAMA. 238:(18):1977;1924-1926.
10. Patterson J.E., Andriole V.T. Bacterial urinary tract infections in diabetes. Infect. Dis. Clin. North Am. 11:(3):1997;735-750.
11. Nicolle L.E., Friesen D., Harding G.K., et al. Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992, impact of diabetes, pregnancy, and aboriginal origin. Clin. Infect. Dis. 22:(6):1996;1051-1056.
12. Wheat L.J. Infection and diabetes mellitus. Diabetes Care. 3:(1):1980;187-197.
13. Sobel J.D., Kaye D. Urinary tract infections. In: Mandell G.L., Bennett J.E., Dolin R., (eds.), Principles and practice of infectious diseases. Churchill Livingstone, New York (NY) 1995;662-690.
14. Podschun R., Sievers D., Fischer A., et al. Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections. J. Infect. Dis. 168:(6):1993;1415-1421.
15. Mulvey M.A., Schilling J.D., Martinez J.J., et al. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc. Natl. Acad. Sci. USA. 97:(16):2000;8829-8835.
16. Geerlings S.E., Brouwer E.C., Gaastra W., et al. Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals. J. Med. Microbiol. 48:(6):1999;535-539.
17. Geerlings S.E., Stolk R.P., Camps M.J.L., et al. Risk factors for symptomatic urinary tract infection in women with diabetes mellitus. Diabetes Care. 23:(12):2000;1737-1741.
18. Delamaire M., Maugendre D., Moreno M., et al. Impaired leucocyte functions in diabetic patients. Diabetes Med. 14:(1):1997;29-34.
19. Balasoiu D., Van Kessel K.C., Van Kats-Renaud H.J., et al. Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care. 20:(3):1997;392-395.
20. Wang Q.N., Qiu Z.D. Infection in acute leukemia: an analysis of 433 episodes. Rev. Infect. Dis. 11:(Suppl 7):1989;S1613-S1620.
21. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:(7):1998;436-445.
22. Geerlings S.E., Brouwer E.C., Van Kessel K.C.P.M., et al. Cytokine secretion is impaired in women with diabetes mellitus. Eur. J. Clin. Invest. 30:(11):2000;995-1001.
23. Geerlings S.E., Meiland R., Van Lith E.C., et al. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in controls. Diabetes Care. 25:2002;1405-1409.
24. Mulvey M.A., Schilling J.D., Hultgren S.J. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 69:(7):2001;4572-4579.
25. Geerlings S.E., Brouwer E.C., Gaastra W., et al. Is a second urine necessary for the diagnosis of asymptomatic bacteriuria? Clin. Infect. Dis. 31:(3):2000;E3-E4.
26. Zhanel G.G., Nicolle L.E., Harding G.K.M., et al. Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus. Clin. Infect. Dis. 21:(2):1995;316-322.
27. Stamm W.E., Hooton T.M. Management of urinary tract infections in adults. N. Engl. J. Med. 329:(18):1993;1328-1334.
28. Geerlings S.E., Stolk R.P., Camps M.J.L., et al. Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch. Int. Med. 161:(11):2001;1421-1427.
29. Frimodt-MØller C. Diabetic cystopathy: epidemiology and related disorders. Ann. Int. Med. 92:(2 (Part 2)):1980;318-321.
30. Vejlsgaard R. Studies on urinary infection in diabetics. II Significant bacteriuria in relation to long-term diabetic manifestations. Acta Med. Scand. 179:1966;183-188.
31. Nicolle L.E. A practical guide to antimicrobial management of complicated urinary tract infection. Drug. Aging. 18:(4):2001;243-254.
32. Lye W.C., Chan R.K.T., Lee E.J.C., et al. Urinary tract infections in patients with diabetes mellitus. J. Infect. 24:1992;169-174.
33. Johnson J.R., Stamm W.E. Urinary tract infections in women: diagnosis and treatment. Ann. Int. Med. 111:(11):1989;906-917.
34. Hooton T.M., Scholes D., Stapleton A.E., et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N. Engl. J. Med. 343:(14):2000;992-997.
35. Ronald A.R., Patullo L.S. The natural history of urinary infections in adults. Infect. Dis. Clin. North Am. 75:(2):1991;299-312.
36. Stein G., Funfstuck R. Asymptomatic bacteriuria - what to do. Nephrol. Dial. Transpl. 14:(7):1999;1618-1621.
37. Zhanel G.G., Harding G.K.M., Guay D.R.P. Asymptomatic bacteriuria. Which patients should be treated? Arch. Int. Med. 150:(7):1990;1389-1396.
38. Nelson R.G., Knowler W.C., Pettitt D.J., et al. Kidney diseases in diabetes. Diabetes in America. 1995;349-401 National Diabetes Data Group, Bethesda (MD).
39. Ritz E., Orth S.R. Nephropathy in patients with type 2 diabetes mellitus. N. Engl. J. Med. 341:(15):1999;1127-1133.
40. Forland M., Thomas V.L. The treatment of urinary tract infections in women with diabetes mellitus. Diabetes Care. 8:(5):1985;499-506.
41. Calvet H.M., Yoshikawa T.T. Infections in diabetes. Infect. Dis. Clin. North Am. 15:(2):2001;407-421.
42. Saiki J., Vaziri N.D., Barton C. Perinephric and intranephric abscesses: a review of the literature. Western J. Med. 136:(2):1982;95-102.
43. Ronald A.R., Harding G.K.M. Complicated urinary tract infections. Infect. Dis. Clin. North Am. 11:(3):1997;583-593.
44. Ronald A., Ludwig E. Urinary tract infections in adults with diabetes. Int. J. Antimicrob. Agents. 17:(4):2001;287-292.
45. Melekos M.D., Naber K.G. Complicated urinary tract infections. Int. J. Antimicrob. Agents. 15:(4):2000;247-256.
46. Nicolle L.E. Asymptomatic bacteriuria in diabetic women. Diabetes Care. 23:(6):2000;722-723.
47. Harding G.K., Zhanel G.G., Nicolle L.E., Cheang M. Manitoba diabetes urinary tract infection study group. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N. Engl. J. Med. 347:(20):2002;1617-1618.
48. Geerlings SE, Meiland R, Hoepelman IM, Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N. Engl. J. Med., in press.
49. Warren J.W., Abrutyn E., Hebel J.R., et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin. Infect. Dis. 29:(4):1999;745-758.
50. Poretsky L., Moses A.C. Hypoglycemia associated with trimethoprim/sulfamethoxazole therapy. Diabetes Care. 7:(5):1984;508-509.
51. Veyssier P, Botto H, Jean C, et al., 5 Day- versus 10 Day-Ofloxacin (OFL) treatment in complicated lower urinary tract infections (LUTI) in women (W) [abstract L1057]. 41th Interscience Congres on Antimicrobial Agents and Chemotherapy, 2001 December 16-19; American Society for Microbiology, Chicago, 464.
52. Schaeffer A.J. Bacterial urinary tract infections in diabetes. J. Urol. 160:(1):1998;293.
53. Raz R., Naber K.G., Raizenberg C., et al. Ciprofloxacin 250 mg twice daily versus ofloxacin 200 mg twice daily in the treatment of complicated urinary tract infections in women. Eur. J. Clin. Microbiol. Infect. Dis. 19:(5):2000;327-331.
54. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS project. J. Antimicrob. Chemother. 51:(1):2003;69-76.
55. Rubin R.H., Shapiro E.D., Andriole V.T., et al. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin. Infect. Dis. 15:(Suppl 1):1992;S216-S227.
56. Talan D.A., Stamm W.E., Hooton T.M., et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA. 283:(12):2000;1583-1590.
57. Chen M.T., Huang C.N., Chou Y.H., et al. Percutaneous drainage in the treatment of emphysematous pyelonephritis: 10-year experience. J. Urol. 157:(5):1997;1569-1573.
58. Gupta K., Scholes D., Stamm W.E. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 281:(8):1999;736-738.
59. Lowe F.C., Fagelman E. Cranberry juice and urinary tract infections: what is the evidence? Urology. 57:(3):2001;407-413.
60. Boris S., Suarez J.E., Vazquez F., et al. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect. Immun. 66:(5):1998;1985-1989.
61. Kontiokari T., Sundqvist K., Nuutinen M., et al. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 322:(7302):2001;1571-1573.
62. Raz R., Stamm W.E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infection. N. Engl. J. Med. 329:(11):1993;753-756.
63. Hextall A. Oestrogens and lower urinary tract function. Maturitas. 36:(2):2000;83-92.
64. Brown J.S., Vittinghoff E., Kanaya A.M., et al. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet. Gynecol. 98:(6):2001;1045-1052.
65. Langermann S., Palaszynski S., Barnhart M., et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science. 276:(5312):1997;607-611.
66. Langermann S., Mollby R., Burlein J.E., et al. Vaccination with FimH adhesin protects cynomolgus monkeys from colonisation and infection by uropathogenic Escherichia coli. J. Infect. Dis. 181:(2):2000;774-778.
67. Meiland R, Geerlings SE, Brouwer EC, et al., Adherence of Escherichia coli to uroepithelial cells of women with diabetes mellitus (DM) can be inhibited by vaccine-induced anti-FimCH antiserum [abstract L1349]. 41th Interscience Congres on Antimicrobial Agents and Chemotherapy; 2001 December 16-19; American Society for Microbiology, Chicago, 468.
68. Uehling D.T., Hopkins W.J., Beierle L.M., et al. Vaginal mucosal immunisation for recurrent urinary tract infection: extended phase II clinical trial. J. Infect. Dis. 183:(Suppl 1):2001;S81-S83.
69. Golden S.H., Peart-Vigilance C., Kao W.H., et al. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 22:(9):1999;1408-1414.
70. Kinane D.F., Blackwell C.C., Brettle R.P., et al. ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women. Br. Med. J. 285:1982;7-9.
71. Scholes D., Hooton T.M., Roberts P.L., et al. Risk factors for recurrent urinary tract infection in young women. J. Infect. Dis. 182:(4):2000;1177-1182.
72. Stapleton A., Stamm W.E. Prevention of urinary tract infection. Infect. Dis. Clin. North Am. 11:(3):1997;719-733.
73. Nicolle L.E. Prevention and treatment of urinary catheter-related infections in older patients. Drug. Aging. 4:(5):1994;379-391.
74. Reid G., Bruce A.W., Taylor M. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin. Ther. 14:(1):1992;11-16.